FDA
- Status: approved
🇺🇸 Rosuvastatin and Ezetimibe morning or evening administration in United States
Rosuvastatin and Ezetimibe morning or evening administration (Rosuvastatin and Ezetimibe morning or evening administration) regulatory status in United States.
Marketing authorisation
Rosuvastatin and Ezetimibe morning or evening administration in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Rosuvastatin and Ezetimibe morning or evening administration approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Rosuvastatin and Ezetimibe morning or evening administration in United States?
Collegium Medicum w Bydgoszczy is the originator. The local marketing authorisation holder may differ — check the official source linked above.